In The Press

Watch this EyeWire TV feature announcing BELKIN Vision's CE Mark

Feature: From Too Few Drops to DSLT - An Interview With Prof Gerd Auffarth

Health Supplement Feature: Vision of the future for Glaucoma

The State of SLT: Advancing the Technology and its Adoption

Interview: Professor Augusto Azuara-Blanco discusses glaucoma treatment in the blink of an eye

Interview: The Israeli Startup Treating the Silent Thief of Sight

Remote Diagnosis and Treatment of Glaucoma: DSLT's application in telemedicine

BELKIN Vision wins €17.5M from the EU Innovation Council

Watch CEO Daria Lemann Blumenthal in this interview on i24News about our disruptive DSLT glaucoma treatment.

Developing DSLT - Interview with Prof Michael Belkin

Let There Be (Laser) Light - How Updated EGS Guidelines Impact Market Adoption of our Technology

The Glaucoma Treatment That Only Takes Seconds

Listen to this podcast with CEO Daria Lemann Blumenthal about her journey as a woman in medtech.

Read this candid interview with CEO Daria Lemann-Blumenthal

Opinion piece on 'Glaucoma care in a matter of seconds'

Listen (in Hebrew) as Yaakov Eichler interviews Dr. Modi Goldenfeld about regular glaucoma exams and BELKIN Vision’s technology.

BELKIN Vision Completes $12.25 Series B Financing Round

BELKIN Vision Announces $12.2M Raised in Series B Funding

Pushing Boundaries with Advanced Technologies

Company Showcase

Emerging Glaucoma Devices See Beyond IOP

BELKIN Vision COVID-19 update

New Technologies Change Glaucoma Treatment Paradigm

Glaucoma 360 forum provides Vision for 2020

Interview with CEO Daria Lemann-Blumenthall

US Edition Lindstrom's Opinion

Novel DSLT Taking aim at greater access to glaucoma care

Glaucoma Laser Developer BELKIN Vision raises $5M